• The biomedical division of CFD Research Corporation develops innovative solutions for lab-on-chip technologies, point of care devices, chemical and biological sensors, biologically inspired power sources, and systems biology and bioinformatics tools.  The new concepts, designs, prototypes and software are developed through highly competitive government contracts and then adapted, applied and licensed for industrial applications. In 2010, several new programs were launched in areas...

  • Concero Scientific's mission is safeguarding the warfighter and the homeland from biothreats by accelerating prevention, response and control solutions for infectious diseases and bioagents through research, development and integration of cutting-edge life science discoveries.
     

  • Conversant Bio is a worldwide supplier of U.S.-sourced human clinical specimens for research and development applications. Conversant’s product, high quality disease specimens matched with in-depth, privacy-protected clinical information, gives researchers a critical tool in the development of diagnostic tests, prognostic indicators and therapeutic treatments. Oncology, hematology, inflammation, rheumatoid arthritis, lupus, cardiology and normal healthy donors are among the company...

  • CyberGene Diagnostics is a medical knowledge, modeling and simulation company that focuses on complex medical disorders such as acute and chronic pancreatitis. New approaches, as engineered by CyberGene Technologies, are critical for the personalized medicine approach needed for patients with unexpected and unpredictable disorders.  Using new machine learning and modeling technologies, complex medical problems may now be addressed through optimal use of deep biological knowledge, new...

  • DIATHERIX Laboratories is an emerging leader in infectious disease diagnostics and drug resistance detection services. Using a multiplexing platform, DIATHERIX Laboratories has developed a series of molecular differential diagnostic services that enables unprecedented speed and accuracy for health care providers in the identification of disease-producing pathogens, leading to appropriate treatment for patients. DIATHERIX Laboratories is a CLIA certified laboratory.

  • Digital Radiance creates online videogames that teach science and math to teenagers. The company developed HudsonAlpha's top-ranked digital education tool, iCell (more than 100,000 users worldwide), and is currently developing virtual space camp for the U.S. Space and Rocket Center. The company's long-term mission is to create digital education environments that cost-effectively integrate relevant hands-on learning into schools and businesses, helping keep America competitive in the...

  • EGEN, Inc., is a clinical stage biopharmaceutical company focused on developing nucleic acid-based therapeutics for cancer and other difficult to treat diseases using proprietary nanoparticle delivery systems. The company's synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA and small molecules by protecting the therapeutic cargo from degradation, promoting uptake by target cells and facilitating intracellular trafficking. The primary...

  • The Food Security Group is dedicated to meeting the challenge of producing sufficient food to feed the world’s expanding population through the commercialization and proliferation of advanced agricultural technologies. The group works primarily with companies focused on advanced fertilizers,  seed and plant genetics, water utilization, pest and disease control and post harvest efficiency. The Food Security Group actively collaborates with subject matter experts and issue...

  •  

    Foresight Biosciences aims to produce innovation for the advancement of glycobiology research and therapeutics.  According to Ronny, Hughes Ph.D., president and chief scientist at Foresight Biosciences, “The number of glycosylated eukaryotic therapeutic proteins is increasing each year and is driving a growing market for products to assist this research. We have produced a library of enzymes to enable the attachment of carbohydrates and ligands to glycopeptides....
  • Gene Capture is developing a rapid infection detection device for use in point of care medicine.  Using a “Genetic Signature Probe” Gene Capture has been able to detect infectious pathogens in small samples and within a few hours.  After automation and process refinements, the technology is expected to provide results in about an hour.  Gene Capture has negotiated the exclusive worldwide rights to the technology from UAHuntsville.